Skip to main content
OpenTrials

Clinical trial condition

Stage IVB Prostate Cancer AJCC v8

Explore clinical trials studying Stage IVB Prostate Cancer AJCC v8. Study availability and eligibility vary by location and protocol.

62 public trials 27 recruiting studies
Refine in advanced search Browse all conditions

Stage IVB Prostate Cancer AJCC v8 trial results

Recruiting

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

NCT04423211

Conditions
Biochemically Recurrent Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +11 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
View all 341 locations
View Trial Details
Recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

NCT03866382

Conditions
Adenocarcinoma, Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma, +71 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 581 locations
View Trial Details
Recruiting

Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer

NCT04489719

Conditions
Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +11 more
Locations
  • Johns Hopkins University Baltimore, Maryland, United States
  • Bozeman Health Deaconess Hospital Bozeman, Montana, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
  • University of Wisconsin-Madison Madison, Wisconsin, United States
View Trial Details
Recruiting

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

NCT06931340

Conditions
Castration-Sensitive Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +10 more
Locations
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • Kaiser Permanente Dublin Dublin, California, United States
  • Kaiser Permanente-Fremont Fremont, California, United States
View all 200 locations
View Trial Details
Recruiting

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

NCT06632977

Conditions
Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +9 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • Enloe Medical Center Chico, California, United States
View all 108 locations
View Trial Details
Recruiting

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

NCT07200830

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +10 more
Locations
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • AIS Cancer Center at San Joaquin Community Hospital Bakersfield, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
View all 112 locations
View Trial Details

Related conditions